- Raised $4M Seed round, Nov 2023
- Raised $700k Pre-Seed Extension led by Peregrine Ventures, Jun 2023
- Raised $750k Pre-Seed Extension led by Peregrine Ventures, Oct 2022
About
AnserBio is a preclinical stage bio-oncology company based in Nesher, Israel, focused on revolutionizing cancer treatment. The company's innovative technology utilizes proprietary cell-derived nanovesicles (exosomes) to deliver functional p53 tumor suppressor protein directly into cancer cells. This approach aims to restore the body's natural anti-cancer defense mechanism, which is often compromised in over 60% of human cancers due to p53 mutations. AnserBio's therapy is being developed for various aggressive tumor types, including colon cancer, bladder cancer, ovarian cancer, and glioblastoma, and can be used as a monotherapy or in combination with existing treatments. The company holds fully owned intellectual property for its groundbreaking mechanism and has demonstrated compelling preclinical results, showing significant tumor growth suppression and rapid apoptosis in various cancer cell lines. AnserBio was formerly known as ExoProTher.
Funding history · 6 rounds · $6.2M total
Headcount over time
Q&A
- What is AnserBio's primary focus?
- AnserBio is a preclinical stage bio-oncology company focused on developing a novel approach to cancer treatment by delivering healthy p53 protein into tumor cells using proprietary cell-derived nanovesicles (exosomes).
- When was AnserBio founded?
- AnserBio was founded in January 2017.
- What is the total amount of funding AnserBio has raised to date?
- AnserBio has raised a total of $6,450,000 USD across all funding rounds.
- Who are the co-founders of AnserBio?
- The co-founders of AnserBio are Lana Volokh, PhD (Co-founder & CEO) and Alex Tendler, PhD (Co-founder & CTO).
- What types of cancer is AnserBio's therapy being developed for?
- AnserBio's therapy is being developed for various aggressive tumor types, including colon cancer, bladder cancer, ovarian cancer, and glioblastoma.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | anser-bio.com |
|---|---|
| linkedin.com/company/27192102 | |
| facebook.com/ExoProTher |
Identifiers & details
| Legal name | ANSERBIO LTD |
|---|---|
| Former names | ExoProTher Medical |
| Founded | 2017-1 |
| Employees (exact) | 10 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | anser-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515596310 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-01-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | התעשיה 47 נשר |